Edition:
United States

Sonoma Pharmaceuticals Inc (SNOA.OQ)

SNOA.OQ on NASDAQ Stock Exchange Capital Market

1.52USD
16 Oct 2018
Change (% chg)

-- (--)
Prev Close
$1.52
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
23,329
52-wk High
$5.92
52-wk Low
$1.35

Consensus Recommendations

Consensus Recommendation Next Earnings (approx.) Company Fiscal Year
End Month
Last Updated
Outperform -0.59 March 17 Oct 2018

Analyst Recommendations and Revisions

1-5 Linear Scale Current 1 Month
Ago
2 Month
Ago
3 Month
Ago
(1) BUY 1 1 1 1
(2) OUTPERFORM 1 1 1 1
(3) HOLD 1 1 1 1
(4) UNDERPERFORM 0 0 0 0
(5) SELL 0 0 0 0
No Opinion 0 0 0 0
Mean Rating 2.00 2.00 2.00 2.00

Consensus Estimates Analysis

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
  # of Estimates Mean High Low 1 Year
Ago
SALES (in millions)
Quarter Ending Mar-18 3 4.49 4.67 4.29 --
Quarter Ending Mar-19 2 5.18 5.30 5.06 5.01
Year Ending Mar-18 3 17.49 17.67 17.29 --
Year Ending Mar-19 2 19.21 19.79 18.62 18.60
Year Ending Mar-20 2 22.84 22.89 22.78 23.58
Earnings (per share)
Quarter Ending Mar-18 3 -0.59 -0.45 -0.66 --
Quarter Ending Mar-19 2 -0.44 -0.41 -0.47 -0.44
Year Ending Mar-18 3 -2.77 -2.58 -2.87 --
Year Ending Mar-19 2 -1.95 -1.79 -2.10 -1.92
Year Ending Mar-20 2 -1.50 -1.31 -1.69 -1.23

Historical Surprises

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
Estimates vs Actual Estimate Actual Difference Surprise %
SALES (in millions)
Quarter Ending Jun-18 4.21 4.64 0.43 10.28
Quarter Ending Mar-18 4.49 3.65 0.83 18.56
Quarter Ending Dec-17 4.39 4.84 0.45 10.28
Quarter Ending Sep-17 3.95 4.32 0.37 9.49
Quarter Ending Jun-17 3.71 3.84 0.12 3.31

Consensus Estimates Trend

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
  Current 1 Week
Ago
1 Month
Ago
2 Month
Ago
1 Year
Ago
SALES (in millions)
Quarter Ending Mar-18 4.49 -- -- -- --
Quarter Ending Mar-19 5.18 5.18 5.18 5.12 5.01
Year Ending Mar-18 17.49 -- -- -- --
Year Ending Mar-19 19.21 19.21 19.21 18.98 18.60
Year Ending Mar-20 22.84 22.84 22.84 22.84 23.58

Estimates Revisions Summary

  Last Week Last 4 Weeks
Number Of Revisions: Up Down Up Down
Revenue
Quarter Ending Mar-18 -- -- -- --
Quarter Ending Mar-19 0 0 0 0
Year Ending Mar-18 -- -- -- --
Year Ending Mar-19 0 0 0 0
Year Ending Mar-20 0 0 0 0
Earnings